Description

Efficient induction of human mesenchymal stem cells (hMSCs) toward the chondrogenic lineage requires a carefully optimized culture environment. During routine MSC differentiation workflows, inconsistent induction efficiency, insufficient extracellular matrix formation, and variations between cell sources can influence cartilage differentiation outcomes and downstream analysis.

Biofargo hMCDM Human MSC Chondrogenic Differentiation Medium is a complete chondrogenic differentiation medium specifically developed for human mesenchymal stem cell cartilage differentiation research. The formulation contains essential and non-essential amino acids, vitamins, hormones, trace elements, and low concentration fetal bovine serum to provide a supportive environment for MSC chondrogenesis.

Designed for researchers studying MSC to chondrocyte differentiation, Biofargo hMCDM supports both three-dimensional cartilage pellet culture and adherent chondrogenic induction workflows. The medium enables researchers to evaluate cartilage-like tissue formation, proteoglycan deposition, and chondrogenic differentiation performance through commonly used staining and characterization methods.

Biofargo hMCDM is suitable for in vitro human MSC differentiation studies, including chondrogenic differentiation assays, cartilage tissue engineering research, and evaluation of MSC multilineage differentiation potential.

Specifications

Product Name	Biofargo hMCDM Human MSC Chondrogenic Differentiation Medium
Product Type	Human MSC chondrogenic differentiation medium
Application	MSC chondrogenesis induction and cartilage differentiation research
Volume	100 mL
pH	7.1–7.3
Endotoxin	≤0.25 EU/mL
Bacteria/Fungi	Negative
Mycoplasma	Negative
Osmolality	280–320 mOsm/kg·H₂O
Appearance	Pink clear liquid
Storage	-20°C, protected from light
Shelf Life	12 months
Research Use	For research use only

Features

Optimized human MSC chondrogenic differentiation medium for cartilage lineage induction research
Supports MSC to chondrocyte differentiation and cartilage-like matrix formation
Complete formulation containing amino acids, vitamins, hormones, trace elements and low concentration serum
Suitable for three-dimensional cartilage pellet culture workflows
Compatible with adherent MSC chondrogenic differentiation protocols
Supports Alcian Blue staining analysis for cartilage extracellular matrix evaluation
Quality controlled with endotoxin, bacteria, fungi and mycoplasma testing

Performance Data

Human MSC Chondrogenic Differentiation Analysis

Biofargo hMCDM Human MSC Chondrogenic Differentiation Medium was evaluated for its ability to support human mesenchymal stem cell (hMSC) chondrogenic induction. Following differentiation culture, cartilage-like extracellular matrix formation was analyzed using Alcian Blue staining, a commonly used method for detecting sulfated glycosaminoglycans and proteoglycan accumulation during chondrogenesis.

Human MSC chondrogenic differentiation after 19 days of induction with Biofargo hMCDM and Alcian Blue staining analysis

Representative Alcian Blue staining results after 19 days of human MSC chondrogenic differentiation using Biofargo hMCDM. Positive staining indicates cartilage extracellular matrix deposition during MSC differentiation toward the chondrogenic lineage.

Cartilage Pellet Formation During MSC Differentiation

High-density MSC pellet culture is a widely used model for evaluating chondrogenic differentiation potential. Biofargo hMCDM supports cartilage pellet induction workflows by maintaining a suitable environment for cell aggregation, extracellular matrix production, and cartilage-like structure formation.

Representative morphology of human MSC cartilage pellet culture following chondrogenic induction with Biofargo hMCDM.

Applications

Biofargo hMCDM Human MSC Chondrogenic Differentiation Medium is designed for researchers performing human mesenchymal stem cell differentiation studies requiring controlled induction toward the chondrogenic lineage. The medium supports experimental workflows focused on cartilage formation, extracellular matrix production, and MSC differentiation characterization.

Human MSC chondrogenic differentiation research
Supports induction of human mesenchymal stem cells toward chondrocyte-like phenotypes.
MSC to chondrocyte differentiation studies
Used for evaluating the ability of human MSCs to differentiate into cartilage-forming cells.
Chondrogenic differentiation assays
Suitable for in vitro evaluation of MSC cartilage differentiation efficiency and differentiation outcomes.
Cartilage tissue engineering research
Supports studies involving cartilage extracellular matrix formation and cartilage-like tissue development.
MSC pellet culture and three-dimensional differentiation models
Compatible with high-density cell aggregation approaches for cartilage induction.
Alcian Blue staining analysis
Supports evaluation of proteoglycan deposition and cartilage matrix formation after differentiation.
MSC multilineage differentiation studies
Can be combined with osteogenic and adipogenic differentiation systems for comprehensive MSC characterization.
Stem cell biology and regenerative medicine research
Applicable to basic research involving human MSC differentiation mechanisms.

Chondrogenic Differentiation Workflow

Biofargo hMCDM supports commonly used human MSC chondrogenic differentiation workflows, including cartilage pellet induction and adherent differentiation culture.

High-density MSC aggregation for cartilage pellet formation
Culture under standard 37°C and 5% CO₂ conditions
Medium replacement every 2–3 days during induction
18–25 days differentiation period depending on experimental requirements
Final evaluation using cartilage-related staining and characterization methods

For pellet culture, the recommended workflow uses approximately 4 × 10⁵ differentiation cells per tube followed by induction culture. For adherent differentiation, cells are seeded on coated culture vessels and induced after reaching appropriate confluency.

Why Choose Biofargo hMCDM?

Successful MSC chondrogenic differentiation depends on maintaining consistent induction conditions while supporting extracellular matrix production and cartilage-associated phenotype development. Variability in cell source, culture conditions, and induction environments can affect differentiation reproducibility.

Biofargo hMCDM provides a complete human MSC chondrogenic differentiation medium designed to simplify cartilage differentiation workflows. The optimized formulation supports both pellet-based and adherent MSC differentiation models, allowing researchers to investigate cartilage formation, proteoglycan deposition, and chondrogenic differentiation outcomes.

With quality-controlled manufacturing and defined testing parameters including endotoxin, microbial contamination, and mycoplasma screening, Biofargo hMCDM provides a reliable solution for laboratory-scale MSC cartilage differentiation research.

FAQ

What is Biofargo hMCDM Human MSC Chondrogenic Differentiation Medium used for?

Biofargo hMCDM is a complete differentiation medium designed for human mesenchymal stem cell (hMSC) chondrogenic differentiation research, including cartilage lineage induction, chondrocyte differentiation studies, and cartilage extracellular matrix analysis.

What cells can be used with Biofargo hMCDM?

Biofargo hMCDM is designed for human mesenchymal stem cell chondrogenic differentiation workflows. It can be used with human MSC research models requiring induction toward cartilage-like phenotypes.

Does Biofargo hMCDM support MSC pellet culture?

Yes. Biofargo hMCDM supports three-dimensional cartilage pellet culture workflows commonly used for human MSC chondrogenic differentiation studies.

Can Biofargo hMCDM be used for Alcian Blue staining analysis?

Yes. Biofargo hMCDM supports chondrogenic differentiation workflows evaluated by Alcian Blue staining, which is commonly used to analyze cartilage extracellular matrix and proteoglycan deposition.

How long does human MSC chondrogenic differentiation typically require?

According to the recommended workflow, human MSC chondrogenic induction is generally performed for approximately 18–25 days, depending on experimental design and differentiation assessment requirements.

What differentiation methods are supported by Biofargo hMCDM?

Biofargo hMCDM supports both cartilage pellet induction and adherent MSC chondrogenic differentiation workflows.

What quality control tests are performed for Biofargo hMCDM?

Biofargo hMCDM is tested for endotoxin level, bacteria and fungi contamination, and mycoplasma contamination. The product specifications include endotoxin ≤0.25 EU/mL with negative bacteria, fungi, and mycoplasma results.

How should Biofargo hMCDM be stored?

Biofargo hMCDM should be stored at -20°C protected from light. Before use, the medium should be thawed at 4°C overnight and unnecessary repeated freeze-thaw cycles should be avoided.

Does Biofargo hMCDM contain antibiotics?

No. Biofargo hMCDM does not contain penicillin or streptomycin. Additional antibiotics may be added according to specific experimental requirements.

Is Biofargo hMCDM intended for clinical use?

No. Biofargo hMCDM is intended for research use only and is not approved for clinical therapeutic applications.

hMCDM - Human MSC Chondrogenic Differentiation Medium